Editing Economy of Cuba (section)

===Industry===
[[File:Oljepumpe cuba.jpg|thumb|250px|[[Pumpjack]]s in Cuba]]
Industrial production accounted for almost 37% of Cuban GDP or US$6.9&nbsp;billion and employed 24% of the population, or 2,671,000 people, in 1996.<ref>{{Cite web|title=Cuba: Economy|url=https://globaledge.msu.edu/countries/cuba/economy|access-date=13 May 2021|website=globaledge.msu.edu}}</ref> A rally in sugar prices in 2009 stimulated investment and development of sugar processing.

In 2003 Cuba's biotechnology and pharmaceutical industry was gaining in importance.<ref>{{cite news| url=http://www.economist.com/node/2249479 | newspaper=The Economist | title=Truly revolutionary | date=29 November 2003}}</ref> Among the products sold internationally are [[vaccine]]s against various viral and bacterial pathogens. For example, the drug [[Heberprot-P]] was developed as a cure for [[diabetic foot ulcer]] and had success in many developing countries.<ref>{{cite web |url=http://www.rhc.cu/ing/news/health/8587-ecuadorians-benefit-from-cuban-drug-heberprot-p.html |title=Ecuadorians benefit from Cuban drug Heberprot-p |publisher=Radio Havana Cuba |date=12 August 2012 |access-date=8 September 2012 |archive-url=https://web.archive.org/web/20130531080835/http://www.rhc.cu/ing/news/health/8587-ecuadorians-benefit-from-cuban-drug-heberprot-p.html |archive-date=31 May 2013}}</ref> Cuba has also done pioneering work on the development of drugs for cancer treatment.<ref>{{cite web|url=https://podcasts.apple.com/us/podcast/cubas-cancer-revolution/id73802620?i=1000384601643&mt=2|title="Cuba's Cancer Revolution" from The Documentary Podcast by BBC on Apple Podcasts|website=Apple Podcasts|access-date=23 August 2018}}</ref>

Scientists such as V. Verez-Bencomo were awarded international prizes for their biotechnology and sugar cane contributions.<ref>{{Cite book|url=https://books.google.com/books?id=ubnZDAAAQBAJ&q=V.+Verez-Bencomo+prize+sugar+cane+biotechnology&pg=PA190|title=Cuba Business and Investment Opportunities Yearbook Volume 1 Strategic, Practical Information and Opportunities |date=18 April 2016|publisher=Lulu.com|isbn=978-1-4387-7655-2}}{{self-published source|date=February 2020}}</ref>{{self-published inline|date=February 2020}}<ref>{{Cite journal|title=Dr Vicente Vérez Bencomo, director, center for the study of synthetic antigens, university of Havana.|last=Gorry|first=C|pmid=21487355|volume=9|pages=14–15|journal=MEDICC Rev|year=2007|issue=1|doi=10.37757/MR2007V9.N1.4 |s2cid=37435797 |doi-access=free}}</ref>